Click on image to view larger version.

Figure 1 Kaplan-Meier curves for one-year MACE-free survival in patients treated with sirolimus-eluting stents (SES group) and bare metal stents (BMS group). A statistically significant difference was observed between the two groups (p = 0.0003). MACE = major adverse cardiac events including death, myocardial infarction, and target lesion revascularization.